{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:32:51Z","timestamp":1790026371517,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1124\/dmd.118.084236","type":"journal-article","created":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T22:35:11Z","timestamp":1546036511000},"page":"173-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["In Silico Prediction of the Absorption and Disposition of Cefadroxil in Humans using an Intestinal Permeability Method Scaled from Humanized PepT1 Mice"],"prefix":"10.1016","volume":"47","author":[{"given":"Yongjun","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.118.084236_bib1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1021\/mp200275j","article-title":"In silico modeling for the nonlinear absorption kinetics of UK-343,664: a P-gp and CYP3A4 substrate","volume":"9","author":"Abuasal","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.118.084236_bib2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1208\/s12248-009-9111-6","article-title":"Simulations of the nonlinear dose dependence for substrates of influx and efflux transporters in the human intestine","volume":"11","author":"Bolger","year":"2009","journal-title":"AAPS J"},{"key":"10.1124\/dmd.118.084236_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF03190588","article-title":"Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1\/2 be predicted from in-vivo rat data?","volume":"29","author":"Caldwell","year":"2004","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.118.084236_bib4","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s11095-006-9041-2","article-title":"Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model","volume":"23","author":"Cao","year":"2006","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.118.084236_bib5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1124\/jpet.108.141242","article-title":"Humanized mouse lines and their application for prediction of human drug metabolism and toxicological risk assessment","volume":"327","author":"Cheung","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.118.084236_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1517\/17425255.2013.741589","article-title":"Species differences in drug transporters and implications for translating preclinical findings to humans","volume":"9","author":"Chu","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.118.084236_bib7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.xphs.2017.08.015","article-title":"Physiologically based oral absorption modelling to study gut-level drug interactions","volume":"107","author":"Chung","year":"2018","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.118.084236_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jddst.2018.02.013","article-title":"An in vitro-in silico approach for the formulation and characterization of ranitidine gastroretentive delivery systems","volume":"45","author":"Cvijic","year":"2018","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1124\/dmd.118.084236_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2018.06.010","article-title":"Evaluating the intestinal and oral absorption of the prodrug valacyclovir in wildtype and huPepT1 transgenic mice","volume":"155","author":"Epling","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.118.084236_bib10","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1023\/A:1016065715308","article-title":"Comparison between permeability coefficients in rat and human jejunum","volume":"13","author":"Fagerholm","year":"1996","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.118.084236_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00265914","article-title":"Dose-dependent absorption and elimination of cefadroxil in man","volume":"41","author":"Garrigues","year":"1991","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.118.084236_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1146\/annurev.pharmtox.45.120403.100007","article-title":"Cytochrome P450 and xenobiotic receptor humanized mice","volume":"46","author":"Gonzalez","year":"2006","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.118.084236_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0169-409X(96)00436-X","article-title":"Simulation models to predict oral drug absorption from in vitro data","volume":"23","author":"Grass","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/dmd.118.084236_bib14","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1124\/dmd.115.067777","article-title":"In vitro-in vivo extrapolation scaling factors for intestinal P-glycoprotein and breast cancer resistance protein: part II. The impact of cross-laboratory variations of intestinal transporter relative expression factors on predicted drug disposition","volume":"44","author":"Harwood","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.084236_bib15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejps.2018.03.017","article-title":"Exploring gastric emptying rate in minipigs: effect of food type and pre-dosing of metoclopramide","volume":"118","author":"Henze","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.118.084236_bib16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/0091270009333209","article-title":"Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches","volume":"49","author":"Hosea","year":"2009","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.118.084236_bib17","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1124\/dmd.111.044263","article-title":"Species-dependent uptake of glycylsarcosine but not oseltamivir in Pichia pastoris expressing the rat, mouse, and human intestinal peptide transporter PEPT1","volume":"40","author":"Hu","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.084236_bib18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bcp.2016.03.008","article-title":"Species differences in the pharmacokinetics of cefadroxil as determined in wildtype and humanized PepT1 mice","volume":"107","author":"Hu","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.118.084236_bib19","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1021\/mp500497p","article-title":"Development and characterization of a novel mouse line humanized for the intestinal peptide transporter PEPT1","volume":"11","author":"Hu","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.118.084236_bib20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1208\/s12248-009-9098-z","article-title":"Mechanistic approaches to predicting oral drug absorption","volume":"11","author":"Huang","year":"2009","journal-title":"AAPS J"},{"key":"10.1124\/dmd.118.084236_bib21","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3109\/00498254.2011.598582","article-title":"Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs","volume":"41","author":"Huh","year":"2011","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.118.084236_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11095-004-9015-1","article-title":"Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches","volume":"22","author":"Ito","year":"2005","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.118.084236_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1517\/17425250802691074","article-title":"The Simcyp population-based ADME simulator","volume":"5","author":"Jamei","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.118.084236_bib24","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1124\/dmd.104.001347","article-title":"Expression of human cytochromes P450 in chimeric mice with humanized liver","volume":"32","author":"Katoh","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.084236_bib25","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1124\/dmd.115.063305","article-title":"Suppression of pulmonary CYP2A13 expression by carcinogen-induced lung tumorigenesis in a CYP2A13-humanized mouse model","volume":"43","author":"Liu","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.084236_bib26","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1124\/dmd.106.012831","article-title":"The PREgnane X receptor gene-humanized mouse: a model for investigating drug-drug interactions mediated by cytochromes P450 3A","volume":"35","author":"Ma","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.084236_bib27","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1211\/0022357991773320","article-title":"Prediction of clearance, volume of distribution and half-life by allometric scaling and by use of plasma concentrations predicted from pharmacokinetic constants: a comparative study","volume":"51","author":"Mahmood","year":"1999","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.118.084236_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1515\/DMDI.2002.19.1.49","article-title":"Prediction of clearance in humans from in vitro human liver microsomes and allometric scaling. A comparative study of the two approaches","volume":"19","author":"Mahmood","year":"2002","journal-title":"Drug Metabol Drug Interact"},{"key":"10.1124\/dmd.118.084236_bib29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2885.2006.00786.x","article-title":"Interspecies allometric scaling. Part I: prediction of clearance in large animals","volume":"29","author":"Mahmood","year":"2006","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1124\/dmd.118.084236_bib30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2885.2006.00787.x","article-title":"Interspecies allometric scaling: prediction of clearance in large animal species: Part II: mathematical considerations","volume":"29","author":"Martinez","year":"2006","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1124\/dmd.118.084236_bib31","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1124\/dmd.105.005488","article-title":"Human CYP2D6 and mouse CYP2Ds: organ distribution in a humanized mouse model","volume":"33","author":"Miksys","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.084236_bib32","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejps.2013.08.018","article-title":"Animal versus human oral drug bioavailability: do they correlate?","volume":"57","author":"Musther","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.118.084236_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ymgme.2007.09.014","article-title":"A humanized mouse model for the reduced folate carrier","volume":"93","author":"Patterson","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1124\/dmd.118.084236_bib34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejps.2017.03.002","article-title":"Substrate and method dependent inhibition of three ABC-transporters (MDR1, BCRP, and MRP2)","volume":"103","author":"Pedersen","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.118.084236_bib35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1128\/AAC.11.2.331","article-title":"Comparative human oral clinical pharmacology of cefadroxil, cephalexin, and cephradine","volume":"11","author":"Pfeffer","year":"1977","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.118.084236_bib36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/00498254.2015.1007112","article-title":"Predictability of plasma concentration-time curves in humans using single-species allometric scaling of chimeric mice with humanized liver","volume":"45","author":"Sanoh","year":"2015","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.118.084236_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jac\/10.suppl_B.17","article-title":"A review of the bioavailability of cefadroxil","volume":"10 (Suppl B)","author":"Santella","year":"1982","journal-title":"J Antimicrob Chemother"},{"key":"10.1124\/dmd.118.084236_bib38","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.2042-7158.1997.tb06823.x","article-title":"Prediction of the plasma concentration profiles of orally administered drugs in rats on the basis of gastrointestinal transit kinetics and absorbability","volume":"49","author":"Sawamoto","year":"1997","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.118.084236_bib39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3109\/03602532.2012.738687","article-title":"Xenobiotic receptor humanized mice and their utility","volume":"45","author":"Scheer","year":"2013","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.118.084236_bib40","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.drudis.2015.09.002","article-title":"A comparison between genetically humanized and chimeric liver humanized mouse models for studies in drug metabolism and toxicity","volume":"21","author":"Scheer","year":"2016","journal-title":"Drug Discov Today"},{"key":"10.1124\/dmd.118.084236_bib41","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1002\/jps.21287","article-title":"Measurement of dissociation constants (pKa values) of organic compounds by multiplexed capillary electrophoresis using aqueous and cosolvent buffers","volume":"97","author":"Shalaeva","year":"2008","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.118.084236_bib42","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1124\/dmd.107.015263","article-title":"Impact of genetic knockout of PEPT2 on cefadroxil pharmacokinetics, renal tubular reabsorption, and brain penetration in mice","volume":"35","author":"Shen","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.084236_bib43","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1124\/dmd.116.073320","article-title":"Species differences in human and rodent PEPT2-mediated transport of glycylsarcosine and cefadroxil in Pichia pastoris transformants","volume":"45","author":"Song","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.084236_bib44","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1023\/A:1020483911355","article-title":"Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs","volume":"19","author":"Sun","year":"2002","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.118.084236_bib45","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/jps.20481","article-title":"A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry","volume":"95","author":"Tang","year":"2006","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.118.084236_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-198600323-00003","article-title":"Cefadroxil. A review of its antibacterial, pharmacokinetic and therapeutic properties in comparison with cephalexin and cephradine","volume":"32 (Suppl 3)","author":"Tanrisever","year":"1986","journal-title":"Drugs"},{"key":"10.1124\/dmd.118.084236_bib47","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1007\/s11095-006-9020-7","article-title":"In silico modeling of non-linear drug absorption for the P-gp substrate talinolol and of consequences for the resulting pharmacodynamic effect","volume":"23","author":"Tubic","year":"2006","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.118.084236_bib48","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1007\/s11095-017-2242-z","article-title":"In silico absorption analysis of valacyclovir in wildtype and Pept1 knockout mice following oral dose escalation","volume":"34","author":"Yang","year":"2017","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.118.084236_bib49","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0378-5173(99)00147-7","article-title":"A compartmental absorption and transit model for estimating oral drug absorption","volume":"186","author":"Yu","year":"1999","journal-title":"Int J Pharm"},{"key":"10.1124\/dmd.118.084236_bib50","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0169-409X(96)00009-9","article-title":"Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption","volume":"19","author":"Yu","year":"1996","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624077298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624077298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.118.084236","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:19:13Z","timestamp":1739956753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624077298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0090955624077298"],"URL":"https:\/\/doi.org\/10.1124\/dmd.118.084236","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Silico Prediction of the Absorption and Disposition of Cefadroxil in Humans using an Intestinal Permeability Method Scaled from Humanized PepT1 Mice","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.118.084236","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}